期刊文献+

HIV感染者和艾滋病患者抗病毒疗效及耐药分析 被引量:3

Effect of anti-HIV treatment and drug-resistance HIV among infected persons and AIDS
原文传递
导出
摘要 目的研究浙江省宁波市HIV感染者和艾滋病人(HIV/AIDS)抗病毒治疗(HAART)效果和发生耐药情况。方法收集156例HIV-1型阳性病例血样,包括114例AIDS病人和42例未治疗感染者,检测CD4+T淋巴细胞数和HIV病毒载量,通过测序获得pol基因序列,经美国斯坦福大学HIV国际耐药数据库分析,获得毒株耐药情况。结果成功获得42例病例的pol序列;在HIV感染者中,HIV毒株对蛋白酶抑制剂分别有8例潜在耐药和2例中度耐药;在艾滋病人中,病毒载量低于最低检测限(50 IU/mL)的有100例,占87.7%;HIV毒株对核苷类和非核苷类抑制剂分别有4例和5例高度耐药;该人群的CD4+T淋巴细胞绝对数为14~1 060个/μL,平均为(314±28)个/μL。结论宁波市多数HIV感染者和艾滋病人对现有的抗病毒药物敏感,抗病毒治疗效果良好。 Objective To study the effect of anti-HIV treatment and status of drug-resistance among HIV /AIDS patients.Methods Whole blood samples were collected from HIV infected persons with or without anti-HIV treatment and AIDS patients.The absolute number of CD4+ T lymphocyte and virus load of the subjects were detected.The virus RNA was amplified with nested-PCR and then sequenced.The drug resistance of HIV-1 strains isolated were obtained by comparison with Stanford HIV Drug Resistance Database.Results Forty-two sequences of pol gene were obtained.Drug resistance to PIs was detected,including 8 potential resistance and 2 intermediate resistance,in HIV infected persons without treatment.Drug resistance to NRTIs was detected,including 4 high-level resistance,and to NNRTIs was detected,including 5 high-level resistance,in AIDS patients.The mean value of absolute number of CD4+ T lymphocyte was 314±28 /μL,with the lowest of 14/μL and the highest of 1 060/μL.Conclusion Most of HIV/AIDS patients are susceptible to the anti-HIV drug at present and a good treatment effect is achieved.
出处 《中国公共卫生》 CAS CSCD 北大核心 2011年第12期1523-1524,共2页 Chinese Journal of Public Health
关键词 HIV/AIDS 病毒载量 CD4+ 耐药 HIV/AIDS virus load CD4+ drug resistance
  • 相关文献

参考文献9

  • 1Qurishi N, Kreuzberg C, Ltichters G, et al. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection [ J ]. The Lancet, 2003,362 ( 9397 ) : 1708 - 1713.
  • 2Deeks SG. Treatment of antiretroviral-drug-resistant HIV-1 infec- tion[ J ]. The Lancet,2003,362 (9400) :2002 - 2011.
  • 3张旻,尚红,韩晓旭,张子宁,王亚男,刘宝贵,李秀金,刘静,姜拥军,王树祥,张岩,赵斌.中国东北地区未经抗病毒治疗的HIV/AIDS患者HIV毒株的耐药基因变异研究[J].中华微生物学和免疫学杂志,2004,24(11):850-854. 被引量:34
  • 4王艳,邢辉,王哲,程华,王连恩,廖玲洁,李新平,周海卫,阮玉华,邵一鸣.河南省某县HIV感染者耐药性影响因素分析[J].中国公共卫生,2007,23(7):803-805. 被引量:12
  • 5张旻,胡清海,程华,崔为国,韩晓旭,张子宁,王亚男,姜拥军,尚红.HIV感染者抗病毒治疗及性行为情况凋查[J].中国公共卫生,2007,23(9):1055-1056. 被引量:8
  • 6张福杰,王玉,王建,等.国家免费艾滋病抗病毒药物治疗手册[M].2版.北京:人民卫生出版社,2007:12.
  • 7Badri M,Ehrlich R,Wood R, et al. Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendations[J]. AIDS, 2001,15 (9) :1143 - 1148.
  • 8Ibe S, Hotta N,Takeo U,et al. Prevalence of drug-resistant human immunodeficiency virus type 1 in therapy-naive patients and use- fulness of genotype testing [ J ]. Microbiol Immunol, 2003,47 ( 7 ) : 499 - 505.
  • 9Masquelier B, Bhaskaran K, Pillay D, et al. Prevalence of transmit- ted HIV-1 drug resistance and the role of resistance algorithms [ J ]. J Acquir Immune Defic Syndr,2005,40 (5) :505 -511.

二级参考文献37

  • 1李珏,李敬云.HIV耐药性研究进展[J].中国艾滋病性病,2004,10(4):309-311. 被引量:10
  • 2张旻,尚红,韩晓旭,张子宁,王亚男,刘宝贵,李秀金,刘静,姜拥军,王树祥,张岩,赵斌.中国东北地区未经抗病毒治疗的HIV/AIDS患者HIV毒株的耐药基因变异研究[J].中华微生物学和免疫学杂志,2004,24(11):850-854. 被引量:34
  • 3吴亚松,吴昊.HIV的耐药研究进展[J].国外医学(病毒学分册),2004,11(6):190-192. 被引量:3
  • 4张福杰,文毅,于兰,马烨,潘捷,赵燕.艾滋病的抗病毒治疗与我国的免费治疗现状[J].科技导报,2005,23(7):24-29. 被引量:104
  • 5Dealaney S, Zheng N, McQueen P. Emergency of drug-resistant HIV-1 strains from patients on long term ddI therapy. 12th World AIDS Conference. Geneva, 1998, 41: 224.
  • 6Grant RM, Kahn JO, Warmerdam M, et al. Transmission and transmissibility of drug resistant HIV-1. Program and Abstracts of the 9th Conference on Retroviruses and Opportunistic Infections. Seattle, Washington, 2002, 368.
  • 7Durant JCP, Clevenbergh P, Halfon P, et al. Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomized controlled trial. Lancet, 1999, 353: 2195-2199.
  • 8Clevenbergh P, Durant JCP, Halfon P, et al. Persisting long-term benefit of antiretroviral genotypic guided treatment for HIV-infected patients failing on HAART: the VIRADAPT study, week 48 follow up. Antiviral Ther, 1999, 4(Suppl.1): 42.
  • 9Hirsch MS, Conway B, D′Aquila RT, et al. Antiretroviral drug resistance testing in adults with HIV infection. JAMA, 1998, 279: 1984-1991.
  • 10Vandamme AM, Van Laethem K, De Clercq E, et al. Managing resistance to anti-HIV drugs: an important consideration for effective disease management. Drugs, 1999, 57: 337-361.

共引文献51

同被引文献24

引证文献3

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部